MetLife (MET) President Ramy Tadros Receives 115-Share Award

What Happened Ramy Tadros, President, U.S. Business at MetLife, was credited with 115 shares of MetLife common stock on 2026-09-08 at an imputed price of $95.50 per share, a total value of $10,983. This transaction is recorded as an award/acquisition (A) and reflects an imputed reinvestment of dividends into deferred shares rather than an open-market purchase.

Key Details

• Transaction date and price: 2026-09-08 at $95.50 per share
• Shares involved: 115 shares; total value reported $10,983
• Shares owned after transaction: Not specified in the Form 4 filing
• Footnote: Transaction represents imputed reinvestment of dividends on deferred shares under the MetLife Leadership Deferred Compensation Plan (deferred receipt of shares)
• Filing timeliness: Reported on 2026-09-10 for a 2026-09-08 transaction (filed within the typical two-business-day window)

Context These deferred-share credits arise from a compensation/deferral plan and do not represent an open-market purchase or sale, so they are a routine administrative award rather than a direct trading signal. The amount is modest (~$11k) relative to many insider trades.